CHF51.20
0.39%
SIX Swiss Exchange, Sep 29, 05:30 pm CEST. Closed.
ISIN
CH0038389992
Symbol
BION

BB Biotech Stock price

CHF51.20
-4.70 8.41% 1M
+8.00 18.52% 6M
+6.25 13.90% YTD
+15.05 41.63% 1Y
+9.85 23.82% 3Y
-33.55 39.59% 5Y
+0.90 1.79% 10Y
-30.80 37.56% 20Y
SIX Swiss Exchange, Closing price Tue, Sep 29 2026
-0.20 0.39%
ISIN
CH0038389992
Symbol
BION

Is BB Biotech a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
CHF2.8b
Enterprise Value
CHF-286.4m
Net debt
positive
Cash
CHF3.1b
Shares outstanding
55.1m
Valuation (TTM | estimate)
P/E
2.1
P/S
2.9 | 4.3
EV/Sales
negative | negative
EV/FCF
negative
P/B
0.9
Dividends
DPS
CHF2.25
Yield 1Y | 5Y
4.4% | 4.8%
Growth 1Y | 5Y
25.0% | -9.0%
Payout 1Y | 3Y
21.4% | 74.2%
Increased
1 Year
Financials (TTM | estimate)
Revenue
CHF947.6m | CHF652.3m
EBITDA
-
EBIT
CHF909.6m
Net Income
CHF1.3b
Free Cash Flow
CHF302.8m
Growth (TTM | estimate)
Revenue
1,263.1% | 5.8%
EBITDA
-
EBIT
2,250.5%
Net Income
407.5%
Free Cash Flow
-30.5%
Margin
Gross
100.0%
EBITDA
-
EBIT
96.0%
Net
142.4%
Free Cash Flow
32.0%
Financial Health
Equity Ratio
99.8%
Return on Equity
20.8%
ROCE
29.5%
ROIC
11,038.3%
Debt/Equity
0.0
More
EPS
CHF24.5
FCF per Share
CHF5.5
Short interest
-
Employees
10
Rev per Employee
CHF61.7m

BB Biotech Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a BB Biotech forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a BB Biotech forecast:

Buy
89%
Hold
11%

BB Biotech Events

Past Events
JUL
23
Q2 2026 Earnings Call
2 months ago

Financial data from BB Biotech

Jun '26
+/-
%
948 948
1,263% 1,263%
100%
- Direct Costs - -
-
-
948 948
1,304% 1,304%
100%
- Selling and Administrative Expenses 28 28
15% 15%
3%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 910 910
2,250% 2,250%
96%
Net Profit 1,349 1,349
408% 408%
142%

In millions CHF.

Don't miss a Thing! We will send you all news about BB Biotech directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BB Biotech AG is a closed-end investment fund, which engages in investing in biotechnology companies. It focuses on the development and commercialization of novel drugs sectors. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.

Head office Switzerland
Employees 10
Founded 1993
Website www.bbbiotech.ch

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today